RISK OF CARDIOVASCULAR DISEASE IN NON-OBESE INDIVIDUALS WITH NONALCOHOLIC FATTY LIVER DISEASE

被引：0
|
作者：
Arvind, Ashwini [1 ]
Henson, Jacqueline [2 ]
Osganian, Stephanie [3 ]
Nath, Cheryl [4 ]
Steinhagen, Lara [4 ]
Chung, Raymond T. [5 ]
Simon, Tracey G. [6 ]
Corey, Kathleen E. [6 ]
机构：
[1] Univ Texas Southwestern, Dallas, TX USA
[2] Duke Univ, Sch Med, Durham, NC 27706 USA
[3] Massachusetts Gen Hosp, Med Gastrointestinal Unit, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Ctr Liver, Div Gastroenterol, Dept Med, Boston, MA 02114 USA
[6] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1631
引用
收藏
页码：992 / 993
页数：2
相关论文
共 50 条
  • [31] The Mediterranean diet and nonalcoholic fatty liver disease in individuals at high cardiovascular risk
    Rahideh, Seyedeh Tayebeh
    Shidfar, Farzad
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (05) : 654 - 656
  • [32] Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals With Nonalcoholic Fatty Liver Disease
    Corey, Kathleen E.
    Chalasani, Naga
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (07) : 1077 - 1084
  • [33] Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
    Li, Yifang
    Chen, Yanzhen
    Tian, Xing
    Zhang, Shanshan
    Jiao, Jian
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 2029 - 2039
  • [34] Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?
    Jang, Heejoon
    Kim, Won
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (02) : 381 - 383
  • [35] Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
    Targher, Giovanni
    Day, Christopher P.
    Bonora, Enzo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (14): : 1341 - 1350
  • [36] LIMITATION OF THE DIAGNOSTIC SCREENING TOOL FOR NONALCOHOLIC STEATOHEPATITIS IN NON-OBESE JAPANESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Nakamura, A.
    Yoneda, M.
    Sumida, Y.
    Miyoshi, H.
    Nakajima, A.
    Atsumi, T.
    Terauchi, Y.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S205 - S205
  • [37] Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health
    Eslam, Mohammed
    Fan, Jian-Gao
    Mendez-Sanchez, Nahum
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (08): : 713 - 715
  • [38] Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice
    Tu, Lan N.
    Showalter, Megan R.
    Cajka, Tomas
    Fan, Sili
    Pillai, Viju V.
    Fiehn, Oliver
    Selvaraj, Vimal
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [39] Non-alcoholic fatty liver disease in non-obese individuals: Prevalence, pathogenesis and treatment
    Molina-Molina, Emilio
    Krawczyk, Marcin
    Stachowska, Ewa
    Lammert, Frank
    Portincasa, Piero
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (06) : 638 - 645
  • [40] Development and validation of a nomogram for predicting nonalcoholic fatty liver disease in the non-obese Chinese population
    Wang, Jiao
    Tang, Yunliang
    Peng, Kaili
    Liu, Honghong
    Xu, Jixiong
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (10): : 6149 - 6159
12345